Results 41 to 50 of about 8,597,124 (379)

Cross-Species Transmission of Rabbit Hepatitis E Virus to Pigs and Evaluation of the Protection of a Virus-like Particle Vaccine against Rabbit Hepatitis E Virus Infection in Pigs

Vaccines, 2022
We investigated the cross-species transmission of rabbit hepatitis E virus (rb HEV) to pigs and evaluated the cross-protection of a swine (sw) HEV-3 virus-like particle (VLP) vaccine against rb HEV infection in pigs.
Sang-Hoon Han, Hee-Seop Ahn, Hyeon-Jeong Go, Dong-Hwi Kim, Da-Yoon Kim, Jae-Hyeong Kim, Kyu-Beom Lim, Joong-Bok Lee, Seung-Yong Park, Chang-Seon Song, Sang-Won Lee, Yang-Kyu Choi, In-Soo Choi   +12 more
doaj   +1 more source

The use of attenuated isolates of Pepino mosaic virus for cross-protection [PDF]

, 2010
Pepino mosaic virus (PepMV) has recently emerged as a highly infectious viral pathogen in tomato crops. Greenhouse trials were conducted under conditions similar to commercial tomato production.
Hamelink, R., Kaarsemaker, R.C., Schenk, M.F., Stijger, C.C.M.M., Vermunt, A.M.W., Vlugt, R.A.A., van der   +5 more
core   +2 more sources

Durability of Cross-Protection by Different Schedules of the Bivalent HPV Vaccine: the CVT Trial.

Journal of the National Cancer Institute, 2020
BACKGROUND The Costa Rica HPV Vaccine Trial (CVT) has documented cross-protection of the bivalent HPV vaccine against HPV31/33/45 up to seven years after vaccination, even with one dose of the vaccine.
Sabrina H. Tsang, J. Sampson, John Schussler, C. Porras, Sarah Wagner, J. Boland, Bernal Cortés, D. Lowy, J. Schiller, M. Schiffman, T. Kemp, A. Rodriguez, W. Quint, M. Gail, L. Pinto, Paula González, A. Hildesheim, A. Kreimer, R. Herrero   +18 more
semanticscholar   +1 more source

Enhancing Immune Response and Heterosubtypic Protection Ability of Inactivated H7N9 Vaccine by Using STING Agonist as a Mucosal Adjuvant

Frontiers in Immunology, 2019
Influenza vaccines for H7N9 subtype have shown low immunogenicity in human clinical trials. Using novel adjuvants might represent the optimal available option in vaccine development.
Jian Luo, Jian Luo, Xu-ping Liu, Fei-fei Xiong, Fei-xia Gao, Ying-lei Yi, Min Zhang, Ze Chen, Wen-song Tan   +8 more
doaj   +1 more source

Experimental evaluation of the cross-protection between Sheeppox and bovine Lumpy skin vaccines

Scientific Reports, 2020
The Capripoxvirus genus includes three agents: Sheeppox virus, Goatpox virus and Lumpy skin disease virus. Related diseases are of economic importance and present a major constraint to animals and animal products trade in addition to mortality and ...
J. Hamdi, Z. Bamouh, M. Jazouli, Z. Boumart, K. Tadlaoui, O. F. Fihri, M. El Harrak   +6 more
semanticscholar   +1 more source

Live Attenuated African Swine Fever Viruses as Ideal Tools to Dissect the Mechanisms Involved in Cross-Protection

Viruses, 2020
African swine fever (ASF) has become the major threat for the global swine industry. Furthermore, the epidemiological situation of African swine fever virus (ASFV) in some endemic regions of Sub-Saharan Africa is worse than ever, with multiple virus ...
E. López, J. van Heerden, Laia Bosch-Camós, F. Accensi, M. J. Navas, Paula López-Monteagudo, J. Argilaguet, C. Gallardo, S. Pina-Pedrero, M. Salas, J. Salt, F. Rodríguez   +11 more
semanticscholar   +1 more source

Cross-Protective Potential and Protection-Relevant Immune Mechanisms of Whole Inactivated Influenza Virus Vaccines Are Determined by Adjuvants and Route of Immunization

Frontiers in Immunology, 2019
Adjuvanted whole inactivated virus (WIV) influenza vaccines show promise as broadly protective influenza vaccine candidates. Using WIV as basis we assessed the relative efficacy of different adjuvants by carrying out a head-to-head comparison of the ...
Yoshita Bhide, Wei Dong, Inta Gribonika, Daniëlle Voshart, Tjarko Meijerhof, Jacqueline de Vries-Idema, Stephen Norley, Kate Guilfoyle, Sarah Skeldon, Othmar G. Engelhardt, Louis Boon, Dennis Christensen, Nils Lycke, Anke Huckriede   +13 more
doaj   +1 more source

Security risk assessment and protection in the chemical and process industry [PDF]

, 2014
This article describes a security risk assessment and protection methodology that was developed for use in the chemical- and process industry in Belgium. The approach of the method follows a risk-based approach that follows desing principles for chemical
American Petroleum Institute, Arata, Cameron, Dowell, Ellis, Fennelly, Fontaine, Gabbar, Garcia, IAEA (International Atomic Energy Agency), Institute of Security Belgium, Kapp, Landoll, Mannan, Meyer, Norman, Reniers, Reniers, Reniers, Wu   +19 more
core   +1 more source

Cross-Protection of Hepatitis B Vaccination among Different Genotypes

Vaccines, 2020
Hepatitis B (HB) vaccination is the most effective method for preventing HB virus (HBV) infection. Universal HB vaccination containing recombinant HB surface antigens (HBsAg) is recommended.
Takako Inoue, Yasuhito Tanaka
semanticscholar   +1 more source

The Development of a Vaccine Against Meningococcus B Using Reverse Vaccinology

Frontiers in Immunology, 2019
The discovery of vaccine antigens through whole genome sequencing (WGS) contrasts with the classical hypothesis-driven laboratory-based analysis of microbes to identify components to elicit protective immunity. This radical change in scientific direction
Vega Masignani, Mariagrazia Pizza, E. Richard Moxon   +2 more
doaj   +1 more source